These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4472468)

  • 21. Pharmacologic approaches to radiation protection.
    Brizel DM
    J Clin Oncol; 2007 Sep; 25(26):4084-9. PubMed ID: 17827457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Is there any experimental evidence for the application of radioprotective substances in radiotherapy?].
    Huber R; Teichmann B
    Arch Geschwulstforsch; 1971; 37(3):213-45. PubMed ID: 4941521
    [No Abstract]   [Full Text] [Related]  

  • 23. Improvement of lung tumor radiotherapy through differential chemoprotection of normal and tumor tissue.
    Yuhas JM
    J Natl Cancer Inst; 1972 Apr; 48(4):1255-7. PubMed ID: 5023684
    [No Abstract]   [Full Text] [Related]  

  • 24. Sensitizers in radiotherapy.
    Dische S
    Br J Hosp Med; 1982 May; 27(5):502, 507-10. PubMed ID: 7093576
    [No Abstract]   [Full Text] [Related]  

  • 25. Cancer trends: the potential of radiation modifiers.
    Elkon D
    Va Med; 1981 Feb; 108(2):120-4. PubMed ID: 7210858
    [No Abstract]   [Full Text] [Related]  

  • 26. Future development of amifostine as a radioprotectant.
    Werner-Wasik M
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):129-34. PubMed ID: 10348272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation-induced toxicities: the role of radioprotectants.
    Curran WJ
    Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):2-4. PubMed ID: 9794993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amelioration of the pathological changes induced by radiotherapy in normal tissues.
    Rezvani M
    J Pharm Pharmacol; 2008 Aug; 60(8):1037-48. PubMed ID: 18644196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of endogenous histamine in the protective effect of radiation-protective agents].
    Goncharenko EN; Kudriashov IuB; Briedis I
    Dokl Akad Nauk SSSR; 1970; 191(4):948-50. PubMed ID: 5469674
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical trial of a radioprotective medicine: geranyl-hydroquinone in radiotherapeutic treatments].
    Rousseau J; Segal JP
    Sem Ther; 1967 Oct; 43(8):470-6. PubMed ID: 5623999
    [No Abstract]   [Full Text] [Related]  

  • 31. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2.
    Simone CB; Simone NL; Simone V; Simone CB
    Altern Ther Health Med; 2007; 13(2):40-7. PubMed ID: 17405678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new administration schedule for amifostine as a radioprotector in cancer therapy.
    Wagner W; Radmard A; Schönekaes KG
    Anticancer Res; 1999; 19(3B):2281-3. PubMed ID: 10472344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of pentoxifylline as a modifier of radiation therapy.
    Nieder C; Zimmermann FB; Adam M; Molls M
    Cancer Treat Rev; 2005 Oct; 31(6):448-55. PubMed ID: 16225996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Future directions in toxicity prevention.
    Brizel DM
    Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):17-20. PubMed ID: 9794997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Amifostine as a supporting treatment during cancer therapy].
    Jantunen E; Puistola U
    Duodecim; 1999; 115(11):1223-7. PubMed ID: 11877841
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical use of inosine in patients treated by irradiation].
    Kamata R; Haruyama K; Okano J; Maruyama M
    Rinsho Hoshasen; 1968 May; 13(5):328-33. PubMed ID: 5188497
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevention and therapy of radiodermatitis in postoperative radiotherapy following mastectomy].
    Kastratović M; Rödl W
    Fortschr Med; 1971 Aug; 89(22):889-90. PubMed ID: 5154177
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of amifostine to prevent xerostomia in patients receiving radiation therapy.
    Batcha M
    Oncol Nurs Forum; 2000 May; 27(4):615-6. PubMed ID: 10833684
    [No Abstract]   [Full Text] [Related]  

  • 39. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology.
    Bentzen SM
    Nat Rev Cancer; 2006 Sep; 6(9):702-13. PubMed ID: 16929324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and management of radiation myelopathy.
    Ang KK; Stephens LC
    Oncology (Williston Park); 1994 Nov; 8(11):71-6; discussion 78, 81-2. PubMed ID: 7826840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.